| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0003319710373749 |
| P698 | PubMed publication ID | 20682616 |
| P50 | author | George D. Kitas | Q37831495 |
| Helen Griffiths | Q39815397 | ||
| Deborah P.M. Symmons | Q54100237 | ||
| Vasileios F Panoulas | Q91252622 | ||
| Tracey E Toms | Q114716033 | ||
| Naveed Sattar | Q37378984 | ||
| P2093 | author name string | Peter Nightingale | |
| Karen M J Douglas | |||
| Jacqueline P Smith | |||
| P2860 | cites work | Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions | Q37415092 |
| The role of statins for the primary and secondary prevention of coronary heart disease in women | Q37438325 | ||
| Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 | ||
| Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids | Q43591338 | ||
| Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation | Q45004490 | ||
| Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. | Q46852341 | ||
| Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors | Q57751173 | ||
| How to measure renal function in clinical practice | Q24672086 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis | Q33563669 | ||
| Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. | Q33910338 | ||
| Infection and inflammation-induced proatherogenic changes of lipoproteins | Q33935040 | ||
| Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
| Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 | ||
| Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
| Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? | Q34601733 | ||
| The lipid and non-lipid effects of statins | Q35153749 | ||
| Dyslipidemia and rheumatoid arthritis | Q35547301 | ||
| Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis | Q35547305 | ||
| Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis | Q35553035 | ||
| Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome | Q35636932 | ||
| Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis | Q35954510 | ||
| Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions | Q36101622 | ||
| Inflammation and atherosclerosis in rheumatoid arthritis | Q36117564 | ||
| Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study. | Q36790369 | ||
| Systemic inflammation as a risk factor for atherothrombosis | Q36912020 | ||
| Hypertension in rheumatoid arthritis. | Q37158219 | ||
| High density lipoprotein cholesterol and statin trials | Q37264760 | ||
| P433 | issue | 2 | |
| P921 | main subject | inflammation | Q101991 |
| systemic inflammation | Q7663815 | ||
| P304 | page(s) | 167-175 | |
| P577 | publication date | 2010-08-03 | |
| P1433 | published in | Angiology | Q4763277 |
| P1476 | title | Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? | |
| P478 | volume | 62 |
| Q34389286 | A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role |
| Q38738136 | Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders |
| Q88917533 | Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis |
| Q58609925 | Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis |
| Q92464675 | Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment |
| Q38568465 | Cardiovascular comorbidity in rheumatic diseases |
| Q38083042 | Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review |
| Q38745362 | Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis |
| Q42494792 | Free radicals and redox signalling in T-cells during chronic inflammation and ageing |
| Q48508157 | Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study |
| Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
| Q37689920 | Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study. |
| Q38287565 | Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship? |
| Q30643321 | Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data |
| Q38026796 | Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies |
| Q34684331 | Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease |
| Q88310736 | Managing premature atherosclerosis in patients with chronic inflammatory diseases |
| Q47929039 | Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus. |
| Q44832625 | Predictors of endothelial dysfunction in patients with rheumatoid arthritis |
| Q64054343 | Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis |
| Q36812587 | Rheumatoid arthritis and cardiovascular disease: an update on treatment issues |
| Q37343272 | The impact of inflammation on metabolomic profiles in patients with arthritis |
Search more.